Clinical Trial Center (CTC) North is part of MediGate GmbH, a central service unit responsible for supporting and strengthening science and research at the UKE (University Medical Center Hamburg-Eppendorf). The main function of CTC North is to conduct clinical trials and provide suitable organisational support. Another important field of activity is the advisory service for investigators and research scientists at the UKE. Phase I Services Phase I clinical trials from 'first-in-man' to 'proof-of-concept', with interlinking between healthy trial participants and early clinical patient trials. Complete phase I trial surroundings with a highly experienced core team equipped with state-of-the-art technology. Experience in QTc trials (Muse infrastructure is on-site) Data management and compilation of reports Integrated research plans for the same medication permit interconnection between phase I and phase II-IV trials, resulting in shorter timelines for authorization/licensing, thus creating a combination of 'Early clinical research' and 'Late Stage Development'. Phase II-IV Services Conducting phase II to phase IV clinical trials in a university setting. Close cooperation with research specialists. A team of highly qualified and experienced study nurses. A network of general practioners. Data management.